AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
Oncology Today with Dr Neil Love
00:00
Intro
Elisabeth Heath introduces the program, faculty, disclosures, and commercial support from AstraZeneca.
Play episode from 00:00
Transcript
